Drug Trial Radar · NCT02603081
Study to Evaluate SPI-1005 in Adults With Meniere's Disease
Last checked: Nov 19, 2026Latest source record: Jun 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Dec 2015
Primary completion
Aug 2017
Study completion Aug 2017
Sponsor
- Lead sponsor
- Sound Pharmaceuticals, IncorporatedIndustry
- Sponsor type
- Industry
- First posted
- Nov 11, 2015
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 19 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the safety and efficacy of three dose levels of SPI-1005 compared to placebo on vertigo, tinnitus and sensorineural hearing loss in 40 adults with Meniere's disease.
Conditions
- Meniere's Disease
Interventions
SPI-1005Drug
Ebselen is a small molecule mimic and inducer of glutathione peroxidase (GPx). GPx reduces reactive oxygen species by the binding of free radicals to its selenium moiety. Ebselen has strong anti-inflammatory characteristics.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of of Treatment-Emergent Adverse EventsTime frame: 7 weeks
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
House Clinic
Los Angeles, California
New York Otology
New York, New York
MUSC
Charleston, South Carolina
Sound Pharmaceuticals, Inc.
Seattle, Washington
Northwest Ear
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.